Literature DB >> 23085381

What have we learnt about high-density lipoprotein cholesterol measurements during 32 years? Experiences in Finland 1980-2012.

Jaana Leiviskä1, Jouko Sundvall, Georg Alfthan, Riitta Tähtelä, Veikko Salomaa, Matti Jauhiainen, Erkki Vartiainen.   

Abstract

BACKGROUND: High-density lipoprotein cholesterol (HDL-C) is important in risk assessment for cardiovascular disease or metabolic syndrome; however, different direct HDL-C assays may lead to erroneous risk estimates and potentially misclassify people.
METHODS: Data for 30-year HDL-C trends in Finland were obtained from the national FINRISK surveys during 1982-2012 (n=45766) taking into account biases from three external quality assessment programs (EQA). We also compared two different direct HDL-C and turbidimetric apolipoprotein A-I methods using 413 fresh serum samples.
RESULTS: HDL-C concentrations in the Finnish population were on average 1.33 (±0.04) mmol/l for men and 1.62 (±0.05) mmol/l for women after bias-correction. Positive HDL-C trends were observed for both sexes with original data, but trends disappeared after bias-correction. Comparison of two direct HDL-C methods demonstrated concentration-dependent difference. When HDL-C concentrations were <1.0 mmol/l, the mean bias was -12.0% (95% CI -13.5 to -10.0) whereas HDL-C concentrations >1.55 mmol/l showed mean bias of 9.0% (95% CI 7.0-10.5).
CONCLUSIONS: Accurate reporting of HDL-C concentrations at the population level requires proper and regular attendance to reliable EQA programs. We found evidence for a concentration-dependent difference between some direct HDL-C methods, which may cause misclassification of people in cardiovascular risk assessment.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23085381     DOI: 10.1016/j.cca.2012.10.027

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  6 in total

1.  High-sensitivity cardiac troponin I and NT-proBNP as predictors of incident dementia and Alzheimer's disease: the FINRISK Study.

Authors:  Juho Tynkkynen; Jussi A Hernesniemi; Tiina Laatikainen; Aki S Havulinna; Perttu Salo; Stefan Blankenberg; Tanja Zeller; Veikko Salomaa
Journal:  J Neurol       Date:  2016-12-30       Impact factor: 4.849

2.  Apolipoproteins and HDL cholesterol do not associate with the risk of future dementia and Alzheimer's disease: the National Finnish population study (FINRISK).

Authors:  Juho Tynkkynen; Jussi A Hernesniemi; Tiina Laatikainen; Aki S Havulinna; Jouko Sundvall; Jaana Leiviskä; Perttu Salo; Veikko Salomaa
Journal:  Age (Dordr)       Date:  2016-09-23

3.  Impact of estimated HDL particle size via the ratio of HDL-C and apoprotein A-I on short-term prognosis of diabetic patients with stable coronary artery disease.

Authors:  Li-Feng Hong; Bo Yang; Song-Hui Luo; Jian-Jun Li
Journal:  J Geriatr Cardiol       Date:  2014-09       Impact factor: 3.327

4.  Repositioning of the global epicentre of non-optimal cholesterol.

Authors: 
Journal:  Nature       Date:  2020-06-03       Impact factor: 49.962

5.  National trends in total cholesterol obscure heterogeneous changes in HDL and non-HDL cholesterol and total-to-HDL cholesterol ratio: a pooled analysis of 458 population-based studies in Asian and Western countries.

Authors: 
Journal:  Int J Epidemiol       Date:  2020-02-01       Impact factor: 7.196

6.  Experiences from the harmonization of Finnish national population-based health survey data.

Authors:  Laura Paalanen; Hanna Tolonen
Journal:  Scand J Public Health       Date:  2021-10-27       Impact factor: 3.199

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.